Vimarsana
Biggest News Aggregation in the World

Link Therapeutics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Link Therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Link Therapeutics Today - Breaking & Trending Today

MediLink Therapeutics announces a multi-target TMALIN® ADC technology platform license agreement with BioNTech, expanding their global strategic partnership - Vimarsana News

MediLink Therapeutics announces a multi-target TMALIN® ADC technology platform license agreement with BioNTech, expanding their global strategic partnership

SUZHOU, China, May 26, 2024 /PRNewswire/ -- MediLink Therapeutics Co., Ltd. , a clinical-stage biotech company, today announces a new strategic collaboration with BioNTech SE , a next-generation...

MediLink Therapeutics Announces Worldwide Collaboration and License Agreement with Roche - Vimarsana News

MediLink Therapeutics Announces Worldwide Collaboration and License Agreement with Roche

MediLink Therapeutics ("MediLink"), announced today that it has entered into a worldwide collaboration and license agreement with Roche (SIX: RO, ROG; OTCQX: ...

MediLink Therapeutics Announces Strategic Collaboration and Worldwide License Agreement with BioNTech to develop next-generation anti-cancer antibody-drug conjugate - Vimarsana News

MediLink Therapeutics Announces Strategic Collaboration and Worldwide License Agreement with BioNTech to develop next-generation anti-cancer antibody-drug conjugate

/PRNewswire/ -- MediLink Therapeutics ("MediLink"), announced today that it has entered into a strategic research collaboration and worldwide license agreement...

NEXT Oncology and MediLink Therapeutics Take "Team Approach" to Next Level on Phase 1 First in Human Clinical Trial in San Antonio | Region - Vimarsana News

NEXT Oncology and MediLink Therapeutics Take "Team Approach" to Next Level on Phase 1 First in Human Clinical Trial in San Antonio | Region

SAN ANTONIO & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Oct 9, 2023--

Latest Updates of Viva's Portfolio Companies - Vimarsana News

Latest Updates of Viva's Portfolio Companies

/PRNewswire/ -- Even with the ever-changing situation, technological innovation is still the most critical component for biopharmaceutical companies' long-term...